| June 2 |
Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program
With GlaxoSmithKline |
| June 2 |
Antitrust: EU Commission Opens Formal Proceedings Against
Sanofi-Aventis for Possible Procedural Infringement |
| June 2 |
Major Independent Trial Demonstrates Significant Anticancer Benefit
of Zometa in Women with Early-stage Breast Cancer |
| June 2 |
MediGene AG (DE) - MediGene Focuses its Strategy on Oncology and
Immunology |
| June 3 |
New Pfizer Data Presented on CP-751,871 across Non-Small Cell Lung
Cancer and Ewing's Sarcoma |
| June 3 |
Mergent, Inc. Announces Changes to the HealthShares
Metabolic-Endocrine Disorders Index |
| June 3 |
Pfizer Reviews Progress of Oncology Pipeline and New Commercial
Business Unit Structure with Analysts |
| June 3 |
Ingenuity Systems Announces Multi-Year Agreement With Boehringer
Ingelheim |
| June 3 |
GeneGo Extends Agreement With Merck & Co., Inc. |
| June 3 |
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands
Operations in Canada |
| June 3 |
New Improved Dosing Approved for Pennsaid |
| June 3 |
AMSA PharmFree Scorecard Grades U.S. Medical Schools on
Conflict-of-Interest Policies; Only 7 Receive an 'A' |
| June 3 |
Roche NimbleGen and BioDiscovery Form Strategic Alliance to Enhance
CGH Microarrays, Software and Services |
| June 3 |
Altus Pharmaceuticals Reports ALTU-237 Phase 1 Clinical Trial
Results |
| June 4 |
Protez Pharmaceuticals to Be Acquired by Novartis |
| June 4 |
Sunesis Pharmaceuticals Focuses Resources on Development of
Voreloxin (Formerly SNS-595) |
| June 4 |
Low HDL Cholesterol from Gene Variation Not Associated with
Increased Risk of Ischemic Heart Disease |
| June 4 |
Novartis Gains Rights to Promising Hospital Antibiotic in Clinical
Development Through Full Acquisition of Protez Pharmaceuticals |
| June 4 |
Early Communication About an Ongoing Safety Review of Tumor
Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel,
Humira, and Cimzia) |
| June 4 |
Amgen and Wyeth Statement on the FDA Early Communication About
Tumor Necrosis Factor (TNF) Blockers |
| June 5 |
Ipsen to Acquire Tercica |
| June 5 |
Calif. AG Brown To Launch Online Technology To Fight Prescription
Drug Abuse |
| June 5 |
FDA Broadens US Indication for Once-Yearly Reclast as Only
Osteoporosis Treatment Approved for Prevention of Fractures After a
Hip Fracture |
| June 6 |
GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World
Leader in Sirtuin Research and Development |
| June 6 |
US FDA Grants Pediatric Exclusivity for UCB's Keppra |
| June 6 |
European Medicines Agency Recommends Measures to Manage
Contamination of Heparin-containing Medicines |
| June 6 |
Synvista Therapeutics Reports Results of Three Phase 2 Clinical
Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease |
| June 6 |
FDA Announces New Labeling Changes for Regranex |
| June 9 |
QLT Announces Agreement to Sell Aczone to Allergan for
Approximately US$150 Million |
| June 9 |
CytRx Corporation Signs Definitive Agreement to Acquire Innovive
Pharmaceuticals, Inc. |
| June 9 |
New Data Released at Major Diabetes Meeting on Initial Combination
Therapy with Januvia (sitagliptin), Merck's Diabetes Medicine, and
Metformin through Two Years of Treatment |
| June 9 |
Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals
Important Cardiovascular Safety News on Avandia |
| June 9 |
Sucampo Pharma Europe Submits Marketing Authorization Application
in Switzerland |
| June 9 |
Cytrx Corporation Signs Definitive Agreement to Acquire Innovive
Pharmaceuticals, Inc. |
| June 9 |
Noven Provides Update on Daytrana Methylphenidate Transdermal
System |
| June 9 |
Canon Communications LLC Announces the Redesign of Its Medical
Device Link Portal |
| June 9 |
PharmaLinkFHI Acquires UK-Based Matrix Contract Research Ltd. |
| June 10 |
Merck Strengthens Its Prescription Medicines Portfolio in Latin
America |
| June 10 |
Administration Proposes Additional Funding for FDA to Improve Food
and Medical Product Safety |
| June 10 |
ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine
Sulfate 60 mg Extended Release Tablets Due to the Potential for
Oversized Tablets |
| June 10 |
Valeant Pharmaceuticals Divests Argentina |
| June 10 |
Targacept and AstraZeneca Initiate Clinical Trial of AZD3480 in
Adult ADHD |
| June 10 |
RiskMetrics and Glass Lewis Endorse All Four Biogen Idec Director
Nominees |
| June 10 |
11th Annual Survey on Consumer Reaction to DTC Advertising of
Prescription Drugs Reveals: |
| June 10 |
AVI BioPharma Provides Update on New Business Plan: Increased
Pipeline Focus, Skill Base and Strategy, Discontinuation of
AVI–5126 Trial in CABG |
| June 11 |
Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic
Combination Creates Innovator and Generic Pharma Powerhouse |
| June 11 |
LAB Research receives revised demand letter from Akela Pharma |
| June 11 |
Immunicon Files for Strategic Restructuring |
| June 11 |
Global Market for Pharmaceuticals Worth Over $1 Trillion by 2013 |
| June 11 |
Innovation is Rapidly Globalizing: India and China are Becoming
Centers of Pharmaceutical R&D says Kauffman Foundation Study |
| June 12 |
Encorium Group, Inc. Announces Signing of Letter of Intent to
Acquire Prologue Research International, Inc. |
| June 12 |
Encorium Group, Inc. Announces Signing of Letter of Intent to
Combine with Linkcon; Expected Expansion Will Create Global CRO |
| June 12 |
Genentech Settles Dispute Related to Cabilly Patent |
| June 12 |
Jazz Pharmaceuticals Announces Development Timeline Updates |
| June 12 |
Abbott Opens New State-of-the-Art R&D Facility to Help Bring
Medicines to Patients Faster |
| June 12 |
FDA, European Medicines Agency to Consider Additional Test Results
When Assessing New Drug Safety |
| June 13 |
PAREXEL Reaches Agreement to Acquire ClinPhone |
| June 13 |
FDA, European Medicines Agency to Consider Additional Test Results
When Assessing New Drug Safety |
| June 13 |
Sen. Grassley Seeks FDA Scrutiny of Paxil and Suicide Risk |
| June 16 |
Drug Makers Differ Strongly in Policies for Low-income Countries |
| June 16 |
Novartis Vaccines and Diagnostics S.r.l. Withdraws Its Marketing
Authorisation Application for the Pre-pandemic Vaccine Aflunov |
| June 16 |
Ore Pharmaceuticals Focuses Resources on Development of
Repositioned Compounds |
| June 16 |
Biovail Recommends Shareholders Vote to Move Forward from the
Melnyk Lost Years |
| June 16 |
Information for Healthcare Professionals: Antipsychotics |
| June 17 |
FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs |
| June 17 |
IMS Health Reports Global Biotech Sales Grew 12.5 Percent in 2007,
Exceeding $75 Billion |
| June 17 |
Boehringer Ingelheim to Acquire Actimis Pharmaceuticals |
| June 17 |
Reps. Dingell, Stupak Welcome PhRMA Invitation to Discuss DTC
Regulations |
| June 17 |
Decision Resources, Inc. Acquires Manhattan Research |
| June 17 |
Novartis, Pfizer and Merck Take the Lead on Strong Relationships
with Physicians, as Doctors Demand an Expanding Set Of Services |
| June 18 |
Statement Regarding Official Publication of Voluntary Takeover
Offer by Anthiarose Limited |
| June 18 |
Sanofi-aventis Intends to Make a Competing Bid of CzK 1,050 in Cash
Per Share for Zentiva |
| June 18 |
Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide |
| June 18 |
FDA Advisory Committee Unanimously Recommends Approval of
Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis |
| June 18 |
FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures' |
| June 18 |
Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino
Review Period for Acquisition of Kosan Biosciences Incorporated |
| June 18 |
EMEA Recommends Information on Lung Cancer Cases to Be Included in
Exubera Product Information |
| June 18 |
Singapore Reinforces Position as a Global Site for Pharma &
Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17
Billion |
| June 18 |
Majority of Americans Support Legislative Action to Disclose
Pharmaceutical Company Gifts to Physicians |
| June 18 |
Johnson & Johnson Nordic AB Acquires Amic |
| June 19 |
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic
Drugs Advisory Committee (DODAC) Meeting |
| June 20 |
Intas Biopharmaceuticals Ltd. Acquires US-based BPD Inc. |
| June 20 |
Canada's Research-Based Pharmaceutical Companies Invested Over a
Billion Dollars in Research and Development (R&D) in 2007 But
Opportunities Exist for Further Growth, Says Rx&D |
| June 20 |
YM BioSciences Announces FDA Lifts Clinical Hold on Aerolef and
Clearance of a Phase II Clinical Trial |
| June 20 |
Merck Provides Update on U.S. Regulatory Status of MK-0524A (ER
niacin/laropiprant) and MK-0524B (ER
niacin/laropiprant/simvastatin) |
| June 20 |
Should Doctors Be 'Selling' Drugs for the Pharmaceutical Industry? |
| June 23 |
GTC Biotherapeutics Enters Into $257 Million Agreement with Ovation
Pharmaceuticals to Develop and Market ATryn in the U.S. |
| June 23 |
FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane |
| June 23 |
Barrier Therapeutics to Merge Into Stiefel Laboratories |
| June 24 |
Center for Public Integrity: Drug Industry Spent Record Amount
Lobbying in '07 Over a Billion Dollars Spent in the Last 10 Years |
| June 24 |
Federal Action Needed to Fill Antibiotic Pipeline, Says the
Alliance for the Prudent Use of Antibiotics |
| June 25 |
Use of Drug-Releasing Stents Associated With Decrease in Repeat
Procedures to Unblock Coronary Arteries |
| June 25 |
Savings Help the Medicine Go Down |
| June 25 |
New Report: The Truth About Drug Innovation |
| June 25 |
Concerned Shareholders of Biovail Seek Court Order Declaring
Biovail AGM Illegally Convened; |
| June 25 |
Center for Communication Compliance Launches First Regulatory
Resource, Training and Certification Portal for Healthcare
Communicators |
| June 26 |
CBO: Biogenerics Would Save Federal Government $6.6 Billion Over
Ten Years |
| June 26 |
Sen. Grassley Calls on Congress and NIH Leaders to Identify
Conflicts of Interest in Taxpayer Sponsored Medical Research |
| June 26 |
Further Steps in Generation Change at Boehringer Ingelheim |
| June 26 |
AstraZeneca Announces Senior Management Changes at Biologics
Business Unit, MedImmune |
| June 27 |
Bristol-Myers Squibb Completes Acquisition of Kosan Biosciences
Incorporated |
| June 27 |
Schering-Plough and Merck Announce Withdrawal of
Loratadine/Montelukast NDA and Termination of Respiratory Joint
Venture |
| June 27 |
FDA Approves Concerta (methylphenidate HCI) Extended-release
Tablets for Treatment of ADHD (Attention Deficit Hyperactivity
Disorder) in Adults |
| June 30 |
GlaxoSmithKline Responds to FDA on Cervarix and Plans to Submit
Final Study Data for Approval |
| June 30 |
Suspension of Shares for Trading on the Official List, Entry Into
Voluntary Administration |
| June 30 |
ACCME Receives Request for Information from U.S. Senate Special
Committee on Aging |
| June 30 |
A New Citeline Analysis Provides Valuable Clues to Health of Drug
Companies |
| June 30 |
Novexel Discontinues Development of NXL 101 |
| June 30 |
FDA MedWatch- CellCept (mycophenolate mofetil)-Reports Of
Progressive Multifocal Leukoencephalopathy In Patients Treated With
CellCept |
